Page results
-
After almost six months and more than 120,000 vaccinations the Islington Business Design Centre closes as a vaccination centre today (20 August 2021).
-
Patient information leaflet for patients suffering form long COVID who are experiencing breathlessness or changes in their breathing pattern.
-
This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.
-
After delivering more than 80,000 vaccines, the vaccination centre at The Francis Crick Institute closes its doors today (13 August 2021) with the last vaccination taking place at 7pm.
-
The Bidborough House NHS Vaccination Centre has now closed.
-
This provides information about a treatment for uterine fibroids known as ‘transcervical ultrasound-guided radiofrequency ablation’. You may also hear it called by the Manufacturer’s name ‘Sonata®’ for short.
-
A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.
-
This page provides information about the thermoregulatory sweat test (TST).
-
This page has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the bronchus
-
This information has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the oesophagus (gullet).
File results
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0155 - Patient transport policy
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma